Bellerophon Therapeutics
BLPH
#11324
Rank
A$0.22 M
Marketcap
A$0.01803
Share price
-36.84%
Change (1 day)
-80.62%
Change (1 year)

Earnings for Bellerophon Therapeutics (BLPH)

Earnings in 2023 (TTM): -A$16.54 Million

According to Bellerophon Therapeutics 's latest financial reports the company's current earnings are A$5.64 Million. In 2022 the company made an earning of -A$33.63 Million a decrease over its 2021 earnings that were of -A$30.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Bellerophon Therapeutics from 2014 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$16.54 Million-50.84%
2022 -A$33.63 Million11.03%
2021 -A$30.29 Million-24.22%
2020 -A$39.97 Million52.25%
2019 -A$26.26 Million-37.33%
2018 -A$41.89 Million13.34%
2017 -A$36.96 Million3.54%
2016 -A$35.7 Million-48.98%
2015 -A$69.97 Million-22.15%
2014 -A$89.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
A$10.84 B-65,510.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.29 Billion 1,594.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Lantheus Holdings
LNTH
A$0.57 B-3,568.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
-A$0.12 Billion 609.53%๐Ÿ‡บ๐Ÿ‡ธ USA